Napo Pharmaceuticals Inc - Net Worth and Insider Trading

Napo Pharmaceuticals Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Napo Pharmaceuticals Inc owns 1 companies in total, including Jaguar Health Inc (JAGX) .

Click here to see the complete history of Napo Pharmaceuticals Inc’s form 4 insider trades.

Insider Ownership Summary of Napo Pharmaceuticals Inc

Ticker Comapny Transaction Date Type of Owner
JAGX Jaguar Health Inc 2015-05-13 10 percent owner

Napo Pharmaceuticals Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Napo Pharmaceuticals Inc Ownership Network

Ownership Network List of Napo Pharmaceuticals Inc

No Data

Ownership Network Relation of Napo Pharmaceuticals Inc

Insider Network Chart

Napo Pharmaceuticals Inc Owned Company Details

What does Jaguar Health Inc do?

Who are the key executives at Jaguar Health Inc?

Napo Pharmaceuticals Inc is the 10 percent owner of Jaguar Health Inc. Other key executives at Jaguar Health Inc include Chief Scientific Officer Pravin R Chaturvedi , director & CEO & President Lisa A Conte , and Chief Accounting Officer Carol R. Lizak .

Jaguar Health Inc (JAGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jaguar Health Inc (JAGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jaguar Health Inc (JAGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jaguar Health Inc (JAGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jaguar Health Inc Insider Transactions

No Available Data

Napo Pharmaceuticals Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Napo Pharmaceuticals Inc. You might contact Napo Pharmaceuticals Inc via mailing address: 201 Mission Street, Suite 2375, San Francisco Ca 94105.

Discussions on Napo Pharmaceuticals Inc

No discussions yet.